The number needed to treat: A clinically useful nomogram in its proper context

British Medical Journal

Volumn 312, Issue 7028, 1996, Pages 426-429

  Chatellier, Gilles ^a   Zapletal, Eric ^a   Lemaitre, David ^a   Menard, Joël ^b   Degoulet, Patrice ^a  

^a HÔPITAL BROUSSAIS   (France)

^b Clinical Investigation Centre

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MEDICAL DECISION MAKING; NOMOGRAM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030041749     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7028.426     Document Type: Article

References (20)

1. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994;331:1136-42.
2. Naylor CD, Chen E, Strauss B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med 1992;117:916-21.
3. Forrow L, Taylor WC, Arnold RM. Absolutely relative: How research results are summarized can affect treatment decisions. Am J Med 1992;92:121-4.
4. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994;309:761-4.
5. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988;318: 1728-33.
6. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995;310:452-4.
7. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. Boston: Little Brown, 1991.
8. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold, 1982:403-18.
9. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Braun ED, Kaddi TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-77.
10. ISIS4 Collaborative Group. International Study of Infarct Survival 4 (ISIS4): a randomized factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulfate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
11. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. II. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
12. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary by pass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70.
13. Pedersen TR, for the Norwegian Multicenter Study Group. Six-year follow-up of the Norwegian Multicenter Study on timolol after acute myocardial infarction. N Engl J Med 1985;313:1055-8.
14. Viscoli CM, Horwitz RI, Singer BH. Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectivenes. Ann Intern Med 1993;118:99-105.
15. Hypertension Detection and Follow-up Program Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. JAMA 1988;259: 2113-22.
16. The Lipid Research Clinics Investigators. The Lipid Research Clinics Coronary Primary Prevention Program. Results of 6 years of post-trial follow-up. Arch Intern Med 1992;152:1399-410.
17. Tversky A, Kahneman D. Judgement under uncertainty: heuristics and biases. Science 1974;185:1124-31.
18. Chatellier G, Blinowska A, Ménard J, Degoulet P. Do physicians estimate reliably the cardiovascular risk of hypertensive patients? In: Greenes RA, Peterson HE, Protti DJ, eds. MEDINFO 95 Proceedings. Edmonton, Canada: IMIA, 1995:876-9.
19. Grover A, Lowensteyn I, Esrey KL, Steinert Y, Joseph L, Abrahamowicz M. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. BMJ 1995;310:975-8.
20. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1990;121:293-8.